Biotechnology Companies By Operating Cash Flow

LargestBiggest EarnersMost ProfitableMost LiquidHighly LeveragedTop DividendsCapital-HeavyHighest ValuationLargest Workforce
Cash Flow From Operations
Return On Equity
Return On Asset
Profit Margin
Operating Margin
Current Valuation
Shares Outstanding
Shares Owned By Insiders
Shares Owned By Institutions
Number Of Shares Shorted
Price To Earning
Price To Book
Price To Sales
Revenue
Gross Profit
EBITDA
Net Income
Cash And Equivalents
Cash Per Share
Total Debt
Debt To Equity
Current Ratio
Book Value Per Share
Cash Flow From Operations
Short Ratio
Earnings Per Share
Price To Earnings To Growth
Target Price
Number Of Employees
Beta
Market Capitalization
Total Asset
Retained Earnings
Working Capital
Current Asset
Current Liabilities
Cash Flow From OperationsEfficiencyMarket RiskExp Return
1ABBV AbbVie Inc
18.81 B
 0.20 
 1.39 
 0.28 
2AMGN Amgen Inc
11.49 B
 0.20 
 1.50 
 0.30 
3GILD Gilead Sciences
10.83 B
 0.22 
 1.56 
 0.34 
4GMAB Genmab AS
7.77 B
(0.01)
 2.80 
(0.04)
5REGN Regeneron Pharmaceuticals
4.42 B
(0.07)
 2.06 
(0.14)
6BIIB Biogen Inc
2.88 B
(0.06)
 1.76 
(0.11)
7HLN Haleon plc
2.3 B
 0.09 
 1.43 
 0.13 
8UTHR United Therapeutics
1.33 B
(0.10)
 2.30 
(0.22)
9EXEL Exelixis
699.97 M
 0.07 
 2.41 
 0.17 
10NBIX Neurocrine Biosciences
595.4 M
(0.10)
 2.82 
(0.27)
11BMRN Biomarin Pharmaceutical
572.84 M
 0.10 
 1.64 
 0.16 
12HALO Halozyme Therapeutics
479.06 M
 0.33 
 1.46 
 0.48 
13ALKS Alkermes Plc
439.12 M
 0.13 
 1.89 
 0.25 
14CDTTW Conduit Pharmaceuticals
344.8 M
 0.16 
 16.43 
 2.55 
15INCY Incyte
335.34 M
(0.08)
 2.20 
(0.17)
16BTX BlackRock Technology and
277.21 M
(0.39)
 1.82 
(0.70)
17EXAS EXACT Sciences
210.54 M
(0.15)
 2.53 
(0.38)
18GRFS Grifols SA ADR
208.28 M
 0.01 
 2.73 
 0.02 
19BNTX BioNTech SE
207.7 M
(0.07)
 3.26 
(0.23)
20PTGX Protagonist Therapeutics
184.15 M
 0.09 
 6.42 
 0.56 
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Operating Cash Flow reveals the quality of a company's reported earnings and is calculated by deducting company's income taxes from earnings before interest, taxes, and depreciation (EBITDA). In other words, Operating Cash Flow refers to the amount of cash a firm generates from the sales or products or from rendering services. Operating Cash Flow typically excludes costs associated with long-term investments or investment in marketable securities and is usually used by investors or analysts to check on the quality of a company's earnings. Operating Cash Flow shows the difference between reported income and actual cash flows of the company. If a firm does not have enough cash or cash equivalents to cover its current liabilities, then both investors and management should be concerned about the company having enough liquid resources to meet current and long term debt obligations.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY